MetLife Investment Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,161
| Closed | -$84.2K | – | 2851 |
|
|
2025
Q3 | $84.2K | Hold |
6,161
| – | – | ﹤0.01% | 2719 |
|
|
2025
Q2 | $86.6K | Hold |
6,161
| – | – | ﹤0.01% | 2618 |
|
|
2025
Q1 | $83K | Hold |
6,161
| – | – | ﹤0.01% | 2601 |
|
|
2024
Q4 | $109K | Hold |
6,161
| – | – | ﹤0.01% | 2582 |
|
|
2024
Q3 | $118K | Hold |
6,161
| – | – | ﹤0.01% | 2564 |
|
|
2024
Q2 | $134K | Buy |
6,161
+601
| +11% | +$16K | ﹤0.01% | 2461 |
|
|
2024
Q1 | $213K | Hold |
5,560
| – | – | ﹤0.01% | 2171 |
|
|
2023
Q4 | $374K | Hold |
5,560
| – | – | ﹤0.01% | 1853 |
|
|
2023
Q3 | $416K | Sell |
5,560
-272
| -5% | -$24.1K | ﹤0.01% | 1747 |
|
|
2023
Q2 | $537K | Buy |
5,832
+268
| +5% | +$23.9K | ﹤0.01% | 1653 |
|
|
2023
Q1 | $577K | Hold |
5,564
| – | – | ﹤0.01% | 1558 |
|
|
2022
Q4 | $642K | Sell |
5,564
-529
| -9% | -$61.6K | ﹤0.01% | 1484 |
|
|
2022
Q3 | $660K | Hold |
6,093
| – | – | 0.01% | 1438 |
|
|
2022
Q2 | $1.1M | Hold |
6,093
| – | – | 0.01% | 1163 |
|
|
2022
Q1 | $1.04M | Buy |
6,093
+2,150
| +55% | +$405K | 0.01% | 1299 |
|
|
2021
Q4 | $826K | Sell |
3,943
-371
| -9% | -$76.7K | 0.01% | 1214 |
|
|
2021
Q3 | $831K | Hold |
4,314
| – | – | 0.01% | 1223 |
|
|
2021
Q2 | $1.22M | Hold |
4,314
| – | – | 0.01% | 1065 |
|
|
2021
Q1 | $914K | Hold |
4,314
| – | – | 0.01% | 1198 |
|
|
2020
Q4 | $847K | Sell |
4,314
-537
| -11% | -$94.9K | 0.01% | 1210 |
|
|
2020
Q3 | $798K | Sell |
4,851
-519
| -10% | -$85.5K | 0.01% | 1141 |
|
|
2020
Q2 | $745K | Hold |
5,370
| – | – | 0.01% | 1160 |
|
|
2020
Q1 | $336K | Hold |
5,370
| – | – | ﹤0.01% | 1431 |
|
|
2019
Q4 | $588K | Hold |
5,370
| – | – | 0.01% | 1372 |
|
|
2019
Q3 | $556K | Hold |
5,370
| – | – | 0.01% | 1364 |
|
|
2019
Q2 | $689K | Hold |
5,370
| – | – | 0.01% | 1298 |
|
|
2019
Q1 | $685K | Hold |
5,370
| – | – | 0.01% | 1268 |
|
|
2018
Q4 | $671K | Hold |
5,370
| – | – | 0.01% | 1191 |
|
|
2018
Q3 | $1.19M | Hold |
5,370
| – | – | 0.01% | 1055 |
|
|
2018
Q2 | $860K | Buy |
5,370
+508
| +10% | +$64.9K | 0.01% | 1089 |
|
|
2018
Q1 | $454K | Buy |
4,862
+625
| +15% | +$46.7K | 0.01% | 1426 |
|
|
2017
Q4 | $296K | Buy |
+4,237
| New | +$281K | ﹤0.01% | 1718 |
|
Other funds holding MED
SCP
MetLife Investment Management's MED Position: Q4 2025 in Review
MetLife Investment Management sold out of Medifast (MED) in Q4 2025, closing a stake of 6,161 shares — an estimated $84.2K sold.
MetLife Investment Management first reported a position in MED in Q4 2017 and held it in 32 quarters. The position peaked at $1.22M in Q2 2021. 109 funds tracked by Wall St. Rank hold MED as of Q4 2025.
- MetLife Investment Management reported no remaining Medifast position as of Q4 2025 after selling out during the quarter.
- MetLife Investment Management sold 6,161 Medifast shares in Q4 2025, an estimated $84.2K.
- MetLife Investment Management first reported a position in Medifast in Q4 2017 and held it in 32 quarters.
- MetLife Investment Management's Medifast position peaked at $1.22M in Q2 2021.
- 109 funds tracked by Wall St. Rank held Medifast as of Q4 2025.
Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.